Munich-based Twogee Biotech, a biotechnology startup developing customised enzyme solutions for the industrial conversion of biomass into sustainable raw materials, has completed a €2.2 million seed financing round led by High‑Tech Gründerfonds.
The round also included investments from Bayern Kapital and strategic partners AgriFoodTech Venture Alliance and Heinz Entsorgung.
Founded in 2024 by Frank Wallrapp and Helge Jochens in Munich, Twogee Biotech supports industrial partners in converting low-value biomass residues and by-products into second-generation raw materials, with a focus on sugars for bio- and synthetic biology applications.
The company’s approach is built on a predictive development platform that integrates enzyme screening, strain engineering and fermentation to enable more efficient biomass utilisation, shorten development timelines and reduce scale-up risk.
The company plans to use the newly raised capital to further develop its technology and advance commercialisation; initial MVPs and paid pilot projects with industrial partners have already been completed. Twogee intends to pursue a licensing model enabling local enzyme production at customer sites to reduce costs and emissions while supporting decentralised, circular value chains.
Frank Wallrapp, CEO of Twogee Biotech, said that many industrial residual streams contain untapped economic potential and that the company supports partners in accessing this value through solutions designed for straightforward integration and clear commercial benefits.
